Prefer not to jinx it, let Mr Market make it so.... but I can say my target price is several multiples of the current SP and when you look around at the valuations of reasonably successful ASX med-tech listings that have a big cornerstone investor on board, have jumped through all the hoops to arrive at human trials and then have seen good outcomes from those trials... the majority weren’t sitting at a $50m market cap once each of those boxes had been ticked.
Chart, page-45
-
- There are more pages in this discussion • 2,813 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
